Showing 6,201 - 6,220 results of 8,663 for search '(( a ((peer decrease) OR (teer decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 0.58s Refine Results
  1. 6201

    Image_3_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.TIF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an annual average of −1.14% (95% CI –1.25 to −1.04) and − 1.15% (95% CI –1.27 to −1.03) for MS attributable to smoking. …”
  2. 6202

    Image_5_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.TIF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an annual average of −1.14% (95% CI –1.25 to −1.04) and − 1.15% (95% CI –1.27 to −1.03) for MS attributable to smoking. …”
  3. 6203

    Image_2_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.TIF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an annual average of −1.14% (95% CI –1.25 to −1.04) and − 1.15% (95% CI –1.27 to −1.03) for MS attributable to smoking. …”
  4. 6204

    Image_7_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.PDF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an annual average of −1.14% (95% CI –1.25 to −1.04) and − 1.15% (95% CI –1.27 to −1.03) for MS attributable to smoking. …”
  5. 6205

    Image_4_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.TIF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an annual average of −1.14% (95% CI –1.25 to −1.04) and − 1.15% (95% CI –1.27 to −1.03) for MS attributable to smoking. …”
  6. 6206

    Image_8_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.PDF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an annual average of −1.14% (95% CI –1.25 to −1.04) and − 1.15% (95% CI –1.27 to −1.03) for MS attributable to smoking. …”
  7. 6207

    Image_11_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.PDF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an annual average of −1.14% (95% CI –1.25 to −1.04) and − 1.15% (95% CI –1.27 to −1.03) for MS attributable to smoking. …”
  8. 6208

    Image_10_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.PDF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an annual average of −1.14% (95% CI –1.25 to −1.04) and − 1.15% (95% CI –1.27 to −1.03) for MS attributable to smoking. …”
  9. 6209

    Image_6_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.PDF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an annual average of −1.14% (95% CI –1.25 to −1.04) and − 1.15% (95% CI –1.27 to −1.03) for MS attributable to smoking. …”
  10. 6210

    Image_9_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.PDF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an annual average of −1.14% (95% CI –1.25 to −1.04) and − 1.15% (95% CI –1.27 to −1.03) for MS attributable to smoking. …”
  11. 6211

    Conservation in a changing world: assessing the conservation status of an agruculturally adapted species, the Blue Crane. Chapter 2: Population Trends by Christie Craig (21008186)

    Published 2025
    “…I conducted winter and summer aerial surveys in the Western Cape wheatlands (Overberg and Swartland), using transects/distance sampling and one in winter 2021 in the Karoo. …”
  12. 6212

    The most predictive triplets of node centralities (including the number of edges). by Doina Bucur (9155202)

    Published 2020
    “…The centrality triplets appear in decreasing order of the largest minimum <i>R</i><sup>2</sup> across <i>β</i> values at <i>N</i> = 10: these four combinations reach <i>R</i><sup>2</sup> values between 0.96 and 0.95 (and many other triplets, not shown here, also score above <i>R</i><sup>2</sup> = 0.90).…”
  13. 6213

    Microfluidic BBB model for evaluation of Ang2-liposome binding and penetration in static or flow condition. by Iason Papademetriou (1866871)

    Published 2018
    “…D) After 6 days static culture on pit-patterned membrane, TEER of the microfluidic BBB model reached 172 ohm x cm<sup>2</sup> (N = 5 devices), and FITC dextran permeability decreased as a function of molecular weight (N ≥ 3 devices per condition). …”
  14. 6214

    Peripheral inflammation increases the number of recombined Purkinje neurons. by Kirsten Ridder (571651)

    Published 2014
    “…(H and I) Transendothelial electrical resistance (TEER, top panel) decreases and the corresponding capacitance (Ccl, bottom panel) of the bEnd5 endothelial monolayers increases significantly 24 h and 48 h after addition of bone-marrow-derived EVs compared to conditioned medium supernatant after ultracentrifugation. …”
  15. 6215

    Capillary Zone Electrophoresis–Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Li... by Daoyang Chen (4732431)

    Published 2019
    “…According to our modeling data, phosphorylation decreases peptide’s charge roughly by one charge unit, resulting in dramatic decrease in electrophoretic mobility. …”
  16. 6216

    Quantification of Errors in Ordinal Outcome Scales Using Shannon Entropy: Effect on Sample Size Calculations by Pitchaiah Mandava (431210)

    Published 2013
    “…Each trial’s mRS distribution was multiplied with the noise distribution from published mRS inter-rater variability to generate an error percentage for “shift” and dichotomized cut-points. For the SAINT I neuroprotectant trial, considered positive by “shift” mRS while the larger follow-up SAINT II trial was negative, we recalculated sample size required if classification uncertainty was taken into account.…”
  17. 6217

    Functional Performance of Different Venous Limb Options in Simulated Neonatal/Pediatric Cardiopulmonary Bypass Circuits by Luiz Fernando Caneo (4701865)

    Published 2018
    “…Two setups were used with two circuits for each one. In Setup I, a neonatal oxygenator was connected to dual 3/16" ID venous limbs (Circuit A) or to a single 1/4" ID venous limb (Circuit B); and in Setup II, a pediatric oxygenator was connected to dual 1/4" ID venous limbs (Circuit C) or a single 3/8" ID venous limb (Circuit D). …”
  18. 6218

    GENomE wide analysis of sotalol-induced IKr inhibition during ventricular REPOLarization, “GENEREPOL study”: Lack of common variants with large effect sizes by Joe-Elie Salem (4351000)

    Published 2017
    “…</p><p>This study supports the lack of common variants with larger effect sizes than one would expect based on previous ECG genome-wide-association studies.…”
  19. 6219
  20. 6220